Organon & Co. (OGN)
7.385
+0.32
(+4.60%)
USD |
NYSE |
Feb 13, 16:00
7.38
0.00 (0.00%)
After-Hours: 20:00
Organon Cash from Investing (Quarterly) : -115.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co., Inc. | -- |
| Amphastar Pharmaceuticals, Inc. | -19.62M |
| Plus Therapeutics, Inc. | 1.297M |
| Geron Corp. | 13.35M |
| Regeneron Pharmaceuticals, Inc. | 220.30M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 264.00M |
| Cash from Financing (Quarterly) | -76.00M |
| Free Cash Flow | 598.00M |
| Free Cash Flow Per Share (Quarterly) | 0.5716 |
| Free Cash Flow to Equity (Quarterly) | 217.00M |
| Free Cash Flow to Firm (Quarterly) | 235.26M |
| Free Cash Flow Yield | 31.09% |